Key facts
- This page summarizes Julie Jordan's Form 4 filing for Homology Medicines, Inc. (QTTB).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 07 Aug 2023, 21:39.
Julie Jordan - 03 Aug 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- QTTB
- Reported as of
- 03 Aug 2023
- Net transaction value
- -$2,576
- SEC form
- 4
- Accepted by SEC
- 07 Aug 2023, 21:39:25 UTC
- Prior SEC filing
- 04 Aug 2023
- Next SEC filing
- 18 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Alloway, Attorney-in-Fact for Julie Jordan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Julie Jordan filed Form 4 for Homology Medicines, Inc. (QTTB) on 07 Aug 2023.
Change
- Previous filing in this sequence was filed on 04 Aug 2023.
- Current net transaction value: -$2,576.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FIXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,548
- Change %
- +56%
- Price
- $0.000000
- Shares after
- 4,318
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
FIXX
transaction
Common Stock
Sale
- Transaction value
- $606
- Shares
- -436
- Change %
- -10%
- Price
- $1.39
- Shares after
- 3,882
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F2
FIXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +387
- Change %
- +10%
- Price
- $0.000000
- Shares after
- 4,269
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
FIXX
transaction
Common Stock
Sale
- Transaction value
- $152
- Shares
- -109
- Change %
- -2.6%
- Price
- $1.39
- Shares after
- 4,160
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F2
FIXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +4,644
- Change %
- +112%
- Price
- $0.000000
- Shares after
- 8,804
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
FIXX
transaction
Common Stock
Sale
- Transaction value
- $1,818
- Shares
- -1,308
- Change %
- -15%
- Price
- $1.39
- Shares after
- 7,496
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FIXX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,548
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,548
- Exercise price
- Footnotes
- F1, F4
FIXX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -387
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 387
- Exercise price
- Footnotes
- F1, F4
FIXX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -4,644
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,644
- Exercise price
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Julie Jordan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
Footnote F2
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
Footnote F3
The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
Footnote F4
Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.
Footnote F5
Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited.